178 related articles for article (PubMed ID: 1309444)
1. Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation.
Carry M; Korley V; Willerson JT; Weigelt L; Ford-Hutchinson AW; Tagari P
Circulation; 1992 Jan; 85(1):230-6. PubMed ID: 1309444
[TBL] [Abstract][Full Text] [Related]
2. Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery.
Allen SP; Sampson AP; Piper PJ; Chester AH; Ohri SK; Yacoub MH
Coron Artery Dis; 1993 Oct; 4(10):899-904. PubMed ID: 8269196
[TBL] [Abstract][Full Text] [Related]
3. Increased production of cysteinyl leukotrienes in hepatorenal syndrome.
Moore KP; Taylor GW; Maltby NH; Siegers D; Fuller RW; Dollery CT; Williams R
J Hepatol; 1990 Sep; 11(2):263-71. PubMed ID: 2174935
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene biosynthesis in coronary artery disease. Results of the Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) study.
Stodółkiewicz E; Rewerska B; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M; Szczeklik W
Pol Arch Intern Med; 2018 Jan; 128(1):43-51. PubMed ID: 29112183
[TBL] [Abstract][Full Text] [Related]
5. Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma.
Asano K; Lilly CM; O'Donnell WJ; Israel E; Fischer A; Ransil BJ; Drazen JM
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):643-51. PubMed ID: 7499681
[TBL] [Abstract][Full Text] [Related]
6. Sulfido-peptide leukotrienes in coronary heart disease - relationship with disease instability and myocardial ischaemia.
De Caterina R; Giannessi D; Lazzerini G; Bernini W; Sicari R; Cupelli F; Lenzi S; Rugolotto MM; Madonna R; Maclouf J
Eur J Clin Invest; 2010 Mar; 40(3):258-72. PubMed ID: 20415701
[TBL] [Abstract][Full Text] [Related]
7. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis.
Taylor GW; Taylor I; Black P; Maltby NH; Turner N; Fuller RW; Dollery CT
Lancet; 1989 Mar; 1(8638):584-8. PubMed ID: 2564113
[TBL] [Abstract][Full Text] [Related]
8. Urinary leukotriene E4 excretion is increased in type 1 diabetic patients: a quantification by liquid chromatography-tandem mass spectrometry.
Hardy G; Boizel R; Bessard J; Cracowski JL; Bessard G; Halimi S; Stanke-Labesque F
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):291-9. PubMed ID: 16303623
[TBL] [Abstract][Full Text] [Related]
9. Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay.
Tagari P; Ethier D; Carry M; Korley V; Charleson S; Girard Y; Zamboni R
Clin Chem; 1989 Mar; 35(3):388-91. PubMed ID: 2537686
[TBL] [Abstract][Full Text] [Related]
10. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome.
Bernard GR; Korley V; Chee P; Swindell B; Ford-Hutchinson AW; Tagari P
Am Rev Respir Dis; 1991 Aug; 144(2):263-7. PubMed ID: 1650152
[TBL] [Abstract][Full Text] [Related]
11. Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen.
Tagari P; Rasmussen JB; Delorme D; Girard Y; Eriksson LO; Charleson S; Ford-Hutchinson AW
Eicosanoids; 1990; 3(2):75-80. PubMed ID: 2169776
[TBL] [Abstract][Full Text] [Related]
12. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
Tagari P; Becker A; Brideau C; Frenette R; Sadl V; Thomas E; Vickers P; Ford-Hutchinson A
J Pharmacol Exp Ther; 1993 Apr; 265(1):416-25. PubMed ID: 8386242
[TBL] [Abstract][Full Text] [Related]
14. Urinary leukotriene E4 excretion in exercise-induced asthma.
Taylor IK; Wellings R; Taylor GW; Fuller RW
J Appl Physiol (1985); 1992 Aug; 73(2):743-8. PubMed ID: 1328140
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of cysteinyl leukotrienes in monkey and man.
Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
[TBL] [Abstract][Full Text] [Related]
16. Recovery of leukotriene E4 from the urine of patients with airway obstruction.
Drazen JM; O'Brien J; Sparrow D; Weiss ST; Martins MA; Israel E; Fanta CH
Am Rev Respir Dis; 1992 Jul; 146(1):104-8. PubMed ID: 1320817
[TBL] [Abstract][Full Text] [Related]
17. Urinary leukotriene E4 levels during early and late asthmatic responses.
Manning PJ; Rokach J; Malo JL; Ethier D; Cartier A; Girard Y; Charleson S; O'Byrne PM
J Allergy Clin Immunol; 1990 Aug; 86(2):211-20. PubMed ID: 2166758
[TBL] [Abstract][Full Text] [Related]
18. Urine leukotriene E4 levels are elevated in patients with active systemic lupus erythematosus.
Hackshaw KV; Voelkel NF; Thomas RB; Westcott JY
J Rheumatol; 1992 Feb; 19(2):252-8. PubMed ID: 1321246
[TBL] [Abstract][Full Text] [Related]
19. Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina.
Cipollone F; Ganci A; Greco A; Panara MR; Pasquale M; Di Gregorio D; Porreca E; Mezzetti A; Cuccurullo F; Patrignani P
Circulation; 2003 Jan; 107(1):55-61. PubMed ID: 12515743
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of leukotriene biosynthesis: effects on the heart conductance.
Sanak M; Dropinski J; Sokolowska B; Faber J; Rzeszutko M; Szczeklik A
J Physiol Pharmacol; 2010 Feb; 61(1):53-8. PubMed ID: 20228415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
